journal article·2025-05-07Open access

Dual Antibacterial and Soft-Tissue-Integrative Effect of Combined Strontium Acetate and Silver Nitrate on Peri-Implant Environment: Insights from Multispecies Biofilms and a 3D Coculture Model

Marjan Kheirmand-Parizi, Katharina Doll-Nikutta, Carina Mikolai, Dagmar Wirth, Henning Menzel, Meike Stiesch

ACS Applied Materials & Interfaces· Volume 17· Issue 18

Abstract

High Resolution Image Download MS PowerPoint Slide Creation of a biological seal and efficient antibacterial qualities in the peri-implant environment is essential for the success of dental implants. Therefore, novel multifunctional strategies are being developed to address these issues, aiming at the simultaneous improvement of tissue integration and hindering pathological biofilm formation. In this study, we investigated the effect of tissue-promotive strontium acetate (SrAc), antibacterial silver nitrate (AgNO 3 ), and their combination on oral soft tissue cells and an oral multispecies biofilm not only in monoculture setups but also in a three-dimensional (3D) implant-tissue-oral bacterial-biofilm model (INTERbACT model) that takes the naturally occurring interactions into account. Application of SrAc led to improved fibroblast migration in the monoculture setting, without impairment of metabolic activity, even upon additional AgNO 3 administration. Notably, the combined treatment of SrAc and AgNO 3 resulted in a synergistic antibacterial effect during biofilm formation as well as on early matured biofilms. Most interestingly, the antibacterial effect of the combined treatment was even further enhanced within the coculture setup leading to increased bacterial death and decreased biofilm volume. The 3D tissue in the coculture setup underwent the combined treatment with a notable rise in CCL20 and IL-1β levels. Histologically, only the AgNO 3 -treated groups exhibited damage to the integrity of the epithelial barrier. Therefore, the results of this study demonstrated promising dual antibacterial and tissue-integrative characteristics of combined AgNO 3 and SrAc in the dental implant environment. Additionally, the study emphasizes the importance of considering naturally occurring tissue–bacteria interactions for reliable in vitro testing of novel implant materials.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Prosthetic Dentistry and Biomedical Materials Science, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany

Lower Saxony Center for Biomedical Engineering, Implant Research and Development (NIFE), Stadtfelddamm 34, 30625 Hannover, Germany

Helmholtz Centre for Infection Research

Institute for Technical Chemistry, Braunschweig University of Technology, Hagenring 30, 38106 Braunschweig, Germany

Funding

Deutsche Forschungsgemeinschaft · Matrix Evolution project

References (70)

Show source-provided references
1. 10.1111/prd.1209410.1111/prd.12094 ↗
2. 10.3389/fimmu.2019.0020810.3389/fimmu.2019.00208 ↗
3. 10.1111/jcpe.1295610.1111/jcpe.12956 ↗
4. 10.1016/S0022-3913(07)60004-310.1016/S0022-3913(07)60004-3 ↗
5. 10.1111/jre.1256210.1111/jre.12562 ↗
6. 10.1902/jop.2012.12059210.1902/jop.2012.120592 ↗
7. 10.1016/j.dental.2021.02.00510.1016/j.dental.2021.02.005 ↗
8. 10.1016/j.jpor.2015.07.00110.1016/j.jpor.2015.07.001 ↗
9. 10.1002/adhm.20220308610.1002/adhm.202203086 ↗
10. 10.3389/fbioe.2021.78381610.3389/fbioe.2021.783816 ↗
11. 10.1002/adhm.20170054910.1002/adhm.201700549 ↗
12. 10.3390/ijms2315805810.3390/ijms23158058 ↗
13. 10.3389/fbioe.2024.134642610.3389/fbioe.2024.1346426 ↗
14. 10.1021/acsabm.2c0001410.1021/acsabm.2c00014 ↗
15. 10.3390/ma1514502510.3390/ma15145025 ↗
16. 10.3390/met1103045310.3390/met11030453 ↗
17. 10.1016/j.bonr.2020.10027310.1016/j.bonr.2020.100273 ↗
18. 10.1038/s41598-017-15488-110.1038/s41598-017-15488-1 ↗
19. 10.1002/jbm.a.3743910.1002/jbm.a.37439 ↗
20. 10.3390/biomedicines904043110.3390/biomedicines9040431 ↗
21. 10.1563/aaid-joi-D-18-0025310.1563/aaid-joi-D-18-00253 ↗
22. 10.1002/cre2.90310.1002/cre2.903 ↗
23. 10.1016/j.biomaterials.2016.01.01610.1016/j.biomaterials.2016.01.016 ↗
24. 10.3390/jcm1008164110.3390/jcm10081641 ↗
25. 10.4248/IJOS1102710.4248/IJOS11027 ↗
26. 10.1080/1040841X.2023.221166510.1080/1040841X.2023.2211665 ↗
27. 10.3390/ijms1603551710.3390/ijms16035517 ↗
28. 10.3389/fmolb.2020.0003310.3389/fmolb.2020.00033 ↗
29. 10.1111/cmi.1307810.1111/cmi.13078 ↗
30. 10.1371/journal.pone.017397310.1371/journal.pone.0173973 ↗
31. 10.1111/cmi.1320910.1111/cmi.13209 ↗
32. Rodriguez L. G. · 2005 · 23
33. 10.1111/prd.1217910.1111/prd.12179 ↗
34. 10.1155/2016/628562010.1155/2016/6285620 ↗
35. 10.1016/j.actbio.2021.01.00110.1016/j.actbio.2021.01.001 ↗
36. Al Rezk F. · Gen. Dent. · 2018 · 66 · 18
37. 10.3389/fphys.2019.0027010.3389/fphys.2019.00270 ↗
38. 10.1177/0022034596075004140110.1177/00220345960750041401 ↗
39. 10.1186/s40729-021-00316-z10.1186/s40729-021-00316-z ↗
40. 10.1016/j.bioactmat.2020.07.01210.1016/j.bioactmat.2020.07.012 ↗
41. Riss, T. L.; Moravec, R. A.; Niles, A. L.; Duellman, S.; Benink, H. A.; Worzella, T. J.; Minor, L. Assay Guidance Manual [Internet]; NCBI, 2016.
42. 10.1021/acsomega.0c0110810.1021/acsomega.0c01108 ↗
43. 10.3892/mmr.2019.1014110.3892/mmr.2019.10141 ↗
44. Khammissa R. · S. Afr. Dent. J. · 2012 · 67 · 122
45. 10.3390/antibiotics1011135010.3390/antibiotics10111350 ↗
46. 10.1021/acssensors.1c0272210.1021/acssensors.1c02722 ↗
47. 10.1021/acsami.9b0681710.1021/acsami.9b06817 ↗
48. 10.1186/s12903-021-01504-410.1186/s12903-021-01504-4 ↗
49. 10.1038/nrmicro238110.1038/nrmicro2381 ↗
50. 10.3390/coatings1107081010.3390/coatings11070810 ↗
51. 10.1016/j.mtbio.2023.10058610.1016/j.mtbio.2023.100586 ↗
52. 10.5167/uzh-2611010.5167/uzh-26110 ↗
53. 10.1128/MMBR.66.3.486-505.200210.1128/MMBR.66.3.486-505.2002 ↗
54. 10.1186/s12967-022-03636-910.1186/s12967-022-03636-9 ↗
55. 10.1002/jbm.b.3169410.1002/jbm.b.31694 ↗
56. 10.3389/fbioe.2024.134781110.3389/fbioe.2024.1347811 ↗
57. 10.1073/pnas.190173011610.1073/pnas.1901730116 ↗
58. 10.3390/pharmaceutics1107032210.3390/pharmaceutics11070322 ↗
59. 10.1038/s41598-021-88058-110.1038/s41598-021-88058-1 ↗
60. 10.1002/cnma.20230040010.1002/cnma.202300400 ↗
61. 10.1189/jlb.010302410.1189/jlb.0103024 ↗
62. 10.1002/jbm.a.3649010.1002/jbm.a.36490 ↗
63. 10.1016/j.actbio.2012.04.04510.1016/j.actbio.2012.04.045 ↗
64. 10.1177/15440591080870030210.1177/154405910808700302 ↗
65. 10.1111/jre.1236710.1111/jre.12367 ↗
66. 10.1016/j.dental.2014.06.00210.1016/j.dental.2014.06.002 ↗
67. 10.3390/ma1605202710.3390/ma16052027 ↗
68. 10.1111/prd.1210410.1111/prd.12104 ↗
69. 10.1016/j.tiv.2019.10473810.1016/j.tiv.2019.104738 ↗
70. 10.1111/jerd.1209710.1111/jerd.12097 ↗